Physical exercise for bone health in men with prostate cancer receiving androgen deprivation therapy: a systematic review
-
Published:2020-10-29
Issue:4
Volume:29
Page:1811-1824
-
ISSN:0941-4355
-
Container-title:Supportive Care in Cancer
-
language:en
-
Short-container-title:Support Care Cancer
Author:
Bressi BarbaraORCID, Cagliari Maribel, Contesini Massimiliano, Mazzini Elisa, Bergamaschi Franco Antonio Mario, Moscato Alfredo, Bassi Maria Chiara, Costi Stefania
Abstract
Abstract
Purpose
Androgen deprivation therapy (ADT) is a treatment used in men with prostate cancer (PCa); however it is responsible for many adverse effects, with negative impact on quality of life. ADT causes loss of bone mineral density (BMD) and skeletal muscle mass, alteration of body composition, and cognitive function, which altogether lead to increased risk of accidental falls and fractures. This systematic review analyses the effectiveness of physical exercise (PE) in preventing accidental falls and fractures and reducing the loss of BMD in men with PCa receiving ADT.
Methods
We searched MEDLINE, EMBASE, CINAHL, and the Cochrane Library for articles between database inception and September 2, 2020. Eligible studies included randomized controlled trials (RCTs) investigating the effects of exercise on bone health in men with PCa receiving ADT.
Results
Nine RCTs were included. Experimental PE consisted in multicomponent programmes that involved aerobic, resistance, impact-loading exercise, and football training. None of the RCTs investigated the risk of accidental falls and fractures, while two trials reported beneficial effects of PE on lumbar spine, hip, and femoral shaft BMD. No further significant difference was detected in the outcomes investigated.
Conclusion
Evidence of the effectiveness of PE to prevent the risk of accidental falls and fractures and BMD loss is lacking. Nevertheless, clinical guidelines recommend PE as a part of the clinical management of men with PCa receiving ADT due to its known numerous health benefits. Research should focus on PE strategies to prevent accidental falls, a clinically relevant outcome in this vulnerable population.
Trial registration
The study protocol was registered with International Prospective Register of Systematic Reviews (PROSPERO, number CRD 42020158444) on 04/28/2020.
Publisher
Springer Science and Business Media LLC
Reference65 articles.
1. World Health Organization. International Agency for Research on Cancer (2018) Cancer Today. https://gco.iarc.fr/today/home. Accessed 2 Sept 2020 2. Mohler JL, Kantoff PW, Armstrong AJ, Bahnson RR, Cohen M, D’Amico AV, Eastham JA, Enke CA, Farrington TA, Higano CS, Horwitz EM, Kawachi MH, Kuettel M, Lee RJ, MacVicar GR, Malcolm AW, Miller D, Plimack ER, Pow-Sang JM, Richey S, Roach M III, Rohren E, Rosenfeld S, Small EJ, Srinivas S, Stein C, Strope SA, Tward J, Walsh PC, Shead DA, Ho M (2013) Prostate cancer, version 1.2014: Featured updates to the NCCN Guidelines. J Natl Compr Canc Netw 11:1471–1479. https://doi.org/10.6004/jnccn.2013.0174 3. Alibhai SMH, Gogov S, Allibhai Z (2006) Long-term side effects of androgen deprivation therapy in men with non-metastatic prostate cancer: a systematic literature review. Crit Rev Oncol Hematol 60:201–215. https://doi.org/10.1016/j.critrevonc.2006.06.006 4. Carneiro A, Sasse AD, Wagner AA, Peixoto G, Kataguiri A, Neto AS, Bianco BAV, Chang P, Pompeo ACL, Tobias-Machado M (2014) Cardiovascular events associated with androgen deprivation therapy in patients with prostate cancer: a systematic review and meta-analysis. World J Urol 33:1281–1289. https://doi.org/10.1007/s00345-014-1439-6 5. Morote J, Gómez-Caamaño A, Alvarez-Ossorio JL, Pesqueira D, Tabernero A, Gómez Veiga F, Lorente JA, Porras M, Lobato JJ, Ribal MJ, Planas J, ANAMET Investigators Group José M Saladié, Gemma Sancho, Humberto Villavicencio, José Segarra, José Comet, José Francisco Suárez Dr., M José Ribal Dr., José Antonio Llorente Dr., Juan Uría Dr., Jesús Guajardo Dr., Antonio Gómez Caamaño Dr., Camilo García Freire Dr., Antonio Ojea Dr., Juan Mata Dr., Mª Luisa Vázquez Dr., Francisco Gómez Veiga Dr., Daniel Pesqueira Dr., Juan Pablo Ciria Dr., Roberto Llarena Dr., Jesús Miguel Unda Dr., Angel José Tabernero Dr., Angel Silmi Dr., Carlos Hernández Dr., Alfredo R (2015) The metabolic syndrome and its components in patients with prostate cancer on androgen deprivation therapy. J Urol 193:1963–1969. https://doi.org/10.1016/j.juro.2014.12.086
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|